(Q36047931)

11 August 2017

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp (English)

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

1 reference

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

author

Manuel Cuenca-Estrella

6

object named as

Manuel Cuenca-Estrella

1 reference

11 August 2017

1

Alicia Gomez-Lopez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

Guillermo Garcia-Effron

2

object named as

Guillermo Garcia-Effron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

3

Emilia Mellado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

author name string

Araceli Monzon

4

1 reference

11 August 2017

Juan L. Rodriguez-Tudela

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

11 August 2017

https://europepmc.org/articles/pmc201144?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://europepmc.org/articles/PMC201144

13 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://europepmc.org/articles/PMC201144?pdf=render

13 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://doi.org/10.1128/aac.47.10.3085-3088.2003

13 March 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://journals.asm.org/doi/pdf/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

Antimicrobial Agents and Chemotherapy

13 March 2024

published in

1 reference

11 August 2017

47

1 reference

11 August 2017

10

1 reference

11 August 2017

3085-3088

1 reference

Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Azole cross-resistance in Aspergillus fumigatus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Uncommon opportunistic fungi: new nosocomial threats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Antifungal drug resistance in Aspergillus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Invasive aspergillosis caused by Aspergillus ustus: case report and review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Aspergillus fumigatus and aspergillosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Itraconazole resistance in Aspergillus fumigatus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus

23 September 2018

1 reference

12 December 2020

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature

1 reference

12 December 2020

<i>Aspergillus fumigatus</i>and Aspergillosis

15

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

Identifiers

1 reference

11 August 2017

1 reference

11 August 2017

1 reference